Home Latest Videos CME Business of Medicine
Doc Life Doc Rant Doc Humor Dueling Doctors
Reuters Health • The Doctor's Channel Daily Newscast
 
Email:

Remember Me

Password:
Trouble Logging In?

Allergy & Clinical Immunology

Alternative Medicine

Anesthesiology

Business of Medicine

Cardiology

Critical Care

Dentistry

Dermatology

Diabetes & Endocrinology

Doc Humor

Doc Rant

Emergency Medicine

Family Medicine

Gastroenterology

Hematology-Oncology

HIV/AIDS

Hospitalist

Human Interest

Infectious Diseases

Internal Medicine

Medical Informatics

Medical Students

Nephrology

Neurology & Neurosurgery

Nurses/NP/PA

Ob/Gyn

Oncology

Ophthalmology

Orthopaedics

Otolaryngology

Pathology & Lab Medicine

Patient Education

Pediatrics

Pharma Film Festival

Pharmacists

Professional Development

Prostate Film Festival

Psychiatry & Mental Health

Public Health & Prevention

Pulmonary Medicine

Radiology

Reuters Health • The Doctor's Channel Daily Newscast

Rheumatology

Sexual Medicine

Sleep Medicine

Surgery

Transplantation

Travel Medicine

Understanding the Burden of Psoriasis

Urology

Veterinary Medicine

Video Job Finder

Women’s Health

 
  Diabetes & Endocrinology
Monofilament testing insufficient to diagnose peripheral neuropathy
Reuters Health • The Doctor's Channel Daily Newscast
Alternate HTML content should be placed here. This content requires the Macromedia Flash Player. Get Flash

 

Rating:  
0 ratings
Views: 3,400 Video Length: 01:36

More in

Diabetes & Endocrinology

Family Medicine

Internal Medicine

Medical Students

Neurology & Neurosurgery

Nurses/NP/PA

Podiatry

Reuters Health • The Doctor's Channel Daily Newscast

Posted: November 10, 2009
NEW YORK (Reuters Health) - Monofilament testing alone is inadequate for diagnosing peripheral neuropathy, according to a systematic literature review done by physicians in The Netherlands.

As the authors note in the Annals of Family Medicine for November/December, “Monofilament testing is an inexpensive, easy-to-use, and portable test for assessing the loss of protective sensation, and it is recommended by several practice guidelines to detect peripheral neuropathy in otherwise normal feet.”

But in fact, Dr. Jacquelien Dros at the University of Amsterdam and colleagues report, “little can be said” about the test’s accuracy for detecting neuropathy in feet without ulcers.

The research team reviewed diagnostic studies in which testing with 5.07/10-g monofilaments was compared to nerve conduction for accuracy in detecting peripheral neuropathy of any cause in patients without visible foot ulcers.

Their literature search turned up only 3 studies that met inclusion criteria, with 37, 126, and 478 subjects, respectively. Each study, however, focused only on patients with diabetes.

The sensitivity of the monofilament test ranged from 41% to 93%, and the specificity ranged from 68% to 100%.

The authors suggest that “these wide ranges are possibly due to differences in application of the monofilament (number and site), interpretation of the monofilament test (definition of thresholds), and differences in study populations.” This clinical heterogeneity prevented performance of a meta-analysis.

Dr. Dros and associates recommend further research on monofilament testing, focusing on optimal standards for test application and on defining a reproducible test threshold.

They concur with the recommendation of the American Diabetes Association that diagnosis of peripheral neuropathy requires a clinical examination with more than one test.

“Tests for this clinical examination are vibration perception (using a 128-Hz tuning fork), pressure sensation (using a 10-g monofilament at least at the distal halluces), ankle reflexes, and pinprick,” the investigators advise. “When in doubt, a nerve conduction test might be necessary to establish a firm diagnosis.”

Reference:
Ann Fam Med 2009;7:555-558.
Comments & Responses
 
Would you like to comment?
Join The Doctor's Channel for a free account, or Login if you are already a member.
Videos in Diabetes & Endocrinology

In diabetics, revascularization more likely after PCI vs ...

186 Views

For schizophrenics, similar cardiac risks with clozapine ...

1134 Views

Platelet rebound not seen after clopidogrel cessation

1146 Views

Is "excellent" glycemic control hazardous for t...

680 Views

Intensive insulin therapy does not improve septic shock m...

522 Views

Atorvastatin does not prevent contrast nephropathy in kid...

990 Views

Thiazolidinediones up risk of fractures in older women

1029 Views

ACE inhibitors, ARBs beat calcium blockers in cutting atr...

590 Views

Diazoxide improves glycemic control in type 1 diabetes

106 Views

Glyburide bests metformin at maintaining glycemic control...

732 Views

Capillary blood glucose test beats HbA1c for mass diabete...

1056 Views

Heart failure benefits vary among different statins

1246 Views

Pravastatin protects against heart disease in blacks

2240 Views

Common meds may lower accuracy of test for Cushing’s sy...

1161 Views

Preprandial insulin aspart started pre-conception may cut...

1604 Views

Mechanical valve needle-free catheter connectors linked t...

3201 Views

Embed